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ABSTRACT 
OBJECTIVE: The purpose of the study was to assess the safety, acceptability and feasibility of 
Visual Inspection with Acetic Acid and Cervicography (VIAC) followed by Cryotherapy or 
Loop Electrical Excision Procedure (LEEP) at a single visit for prevention of cancer of the 
cervix in Bulawayo, Zimbabwe. 
STUDY DESIGN: The study was descriptive using retrospective data extracted from electronic 
medical records of women attending the VIAC clinic at United Bulawayo Hospital in the period 
1
st
 February2010 to 31
st
 December2012.Over 24 months 4641 women visited the clinic and were
screened for cervical cancer using VIAC. If positive and eligible, cryotherapy or LEEP was 
offered immediately. Treated women were followed up at 3months and 1 year. 
RESULTS: The VIAC test positive rate was 10.8%.Of those eligible,17.0% received immediate 
cryotherapy, 44.1%received immediate LEEP, 1.9% delayed treatment and 37.0% were referred 
to a gynaecologist. No major complications were recorded after cryotherapy or LEEP. Among 
those treated99.5% expressed satisfaction with their experience. Only 3.2% of those treated at 
the clinic were VIAC positive one year later. The service was shown to be feasible to sustain 
over time with the necessary consumables. There were no service-related treatment 
postponements and the clinic staff and facility were able to meet the demand for the service. 
CONCLUSION: A single visit approach using VIAC, followed by cryotherapy or LEEP proved 
to be safe, acceptable and feasible in an urban African setting in Bulawayo, Zimbabwe. 
Key words: cervical cancer prevention, cervical cancer screening, cryotherapy, Loop Electrical 
Excision Procedure, visual inspection with acetic acid, cervicography, Zimbabwe. 
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1 INTRODUCTION 
Cancer of the cervix is the most common cancer affecting women in Africa and second only to 
breast cancer worldwide.
1 
This cancer claims approximately 270,000 lives of women annually 
worldwide. Nearly 85% of those deaths occur in resource-poor settings.
1
The reasons for these 
high rates are because preventive strategies and treatment are not well carried out in developing 
countries. In resource limited countries, like Zimbabwe, shortage of skilled health workers, lack 
of political will and insufficient funds towards women’s health activities contribute to these high 
rates.
2 
An additional one million more deaths from cervical cancer are predicted over the “next 
five years worldwide. 
 
Nearly half a million new cases are reported per annum worldwide.
3
Effective and definitive 
treatment is technically possible in the pre-invasive stage of this cancer, although treatment of 
frankly invasive cancer is difficult to impossible in developing countries.
4
The introduction of the 
Papanicolau smear during the late 1940’s in the USA decreased the incidence of invasive cancer 
of the cervix by 70%.Screening has been known to reduce the incidence and mortality rates of 
cervical cancer in developed countries. The cytology based screening programme greatly 
reduced the burden of cervical cancer in developed countries, this approach is difficult to 
implement because of lack of financial and human resources in Zimbabwe. The poorly organized 
health system also contributes to failure in using pap smears as a screening test.
4 
New methods 
which are adaptable to limited resource countries have been investigated and are being used. 
Human papillomavirus (HPV) testing and visual inspection of the cervix with acetic acid (VIA) 
are two adaptable tests being proposed to identify pre-cancerous conditions of the cervix. The 
positive identification of the cause of the disease, which is a limited number of viral serotypes of 
the human papilloma virus (HPV) family, has significantly changed the scope of cervical cancer 
prevention
11 
 
In Sub-Saharan Africa, cancer of the cervix accounts for 22% of all cancers in women.
5 
Effective 
screening programmes have greatly decreased the incidence of cervical cancer in developed 
countries. In many parts of Africa and Asia Oceania on the other hand invasive cervical cancer is 
relatively common, with most of the patients presenting in advanced stages.
5,6 
The true incidence 
of cervical cancer in most African countries is unknown and there is gross under reporting. Only 
a few countries have functional cancer registers and record keeping is minimal or non-existent.
2
 
Some of the figures quoted in the literature are hospital based, which represents a small fraction 
of women dying of cancer of the cervix, as most women cannot access hospital care and die at 
home. 
 
1.1 Screening and Early Detection 
In spite of knowledge of the cause and prevention of cancer of the cervix, successfully 
organized, population-based cervical cancer prevention programmes have not yet been 
implemented in most developing countries. Denny states that contributing factors to this situation 
are poverty, lack of resources and infrastructure, and disenfranchisement ofwomen.
2 
 
Denny suggests that alternative methods of screening for cancer of the cervix like VIA will be 
suitable for low income resource countries.
7
The two most widely studied alternative approaches 
to cervical cancer prevention are visual inspection (with acetic acid or Lugol’s iodine) and HPV-
DNA testing.
2 
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1.2 Visual inspection of the cervix with acetic acid (VIA) 
Visual inspection of the cervix with “acetic acid, also known as direct visual inspection(DVI), 
involves examining the cervix with the naked eye, using a bright light source, after the 
application of 3-5% dilute acetic acid using a cotton swab or a spray”.2Theprocedure involves 
waiting for one minute after the application of the dilute acetic acid. 
 
The advantage of acetic acid is that it is found in vinegar, which is readily available worldwide. 
The area of interest for inspection is the squamo-columnar junction (SCJ), or the area of the 
cervix where squamous epithelium meets columnar epithelium. This area is of interest because 
this is where squamous cell cervical cancer begins.
2
 
 
Unlike the Pap smear method which requires a series of steps both inside and outside the clinic 
to obtain a positive or negative result, the VIA method yields an immediate result. Advantages to 
this approach include the possibility of offering treatment at the same visit where VIA is 
provided, reducing anxiety about waiting for a test result, and eliminating further diagnostic 
procedures.
2 
 
Cryotherapy and LEEP, commonly used for treatment of pre-cancer, have a proven safety and 
effectiveness profile without evidence of adverse anatomical or physiological effects on the 
cervix.
8
 
 
1.3VIAC- Visual Inspection with Acetic acid plus Cervicography 
Cervicography is taking a digital picture of the cervix after VIA with a fairly ordinary camera 
mounted with a special lens.
8,9,10
 The photographs are viewed on a television or computer screen 
and interpreted by trained nurses or doctors.
9,10
Cervicography magnifies the cervix so that it can 
be viewed on a large screen. It also gives a permanent record that can be discussed later with 
colleagues, can be shown to the client and can be compared with previous pictures. 
Cervicography has improved the sensitivity and specificity of VIA.
-
The greatest criticism of VIA 
has always been quality control and VIAC has resolved this as there is now a visual record that 
can be discussed by colleagues and transmitted online.
-
VIAC therefore is Visual Inspection with 
Acetic acid aided by cervicography. 
 
1.4 Immediate post VIAC interventions 
The goal of treatment of pre-cancerous lesions is to remove the lesion and this can be 
accomplished by either ablation (cryotherapy or cautery), excision Loop Electrical Excision 
Procedure (LEEP), cone biopsy or hysterectomy.
11,12,13
All these treatments methods have a good 
success rate. and the choice of treatment depends on the size or extent of the lesion, client 
acceptability, reproductive needs, cost, availability of equipment and expertise. Since VIAC is 
based on a single visit ‘see and treat’ approach only treatment modalities that fit into this 
approach are discussed further: cryotherapy, cautery, LEEP and cone biopsy.
11,12,13 
 
1.4.1 Cryotherapy 
Cryotherapy of the cervix is a method of destroying pre-cancerous cells by cold coagulation 
using ice-cold gas and no local anesthesia.
11,12 
The main disadvantage is that there is no 
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histological specimen available for evaluation. If an aceto-white lesion is visualized during 
VIAC, cryotherapy treatment can be performed.
14,15,16,17
 
 
If the lesion covers >75% of the cervix, disappears into the internal os, there are abnormal 
vessels or gross evidence of cancer the client should be referred for LEEP.
14,15,16,17
 If an aceto-
white lesion is visualized during VIAC , cryotherapy treatment can be performed following set 
criteria. 
14,15,16,17 
 
1.4.2 Loop Electrical Excision Procedure (LEEP)  
LEEP is also called Large Loop Electro-diathermy Excision Procedure and is performed under 
local anesthesia using 2-5 ml lignocaine without adrenaline at 3-, 6-, 9-, and 12 o’clock 
positions. It entails using a wire with an electrical current passing through it to cut and remove 
tissue under direct vision.
11
The wire cuts and simultaneously coagulates.
-
The transformation 
zone, including the lesion, is therefore removed. This can be used as both a diagnostic or 
therapeutic procedure. 
 
Criteria for LEEP:
11
 
 Aceto-white lesion covering > 75% of the transformation zone 
 Lesion disappearing into the os 
 Lesion contains abnormal blood vessel patterns 
 Persistent lesion after cryotherapy 
 There is failure of agreement between cytology, VIAC and histology 
 The limits of the lesion in the cervix cannot be completely defined by VIAC 
1.5 Scientific value of the study 
The main value of the study is to show that a single visit approach to cervical cancer screening is 
acceptable and feasible to staff and patients and the treatment options are safe. Similar projects 
have been undertaken in Ghana
9
, Zambia
11
and Thailand
.16
In Ghana a single-visit approach using 
cyrotherapy proved safe, acceptable and feasible in an urban African setting.
9
 In Ghana and 
Thailand they used VIA, while in Zambia they used VIAC. 
 
In Zambia  the high proportion of women (67%) that accepted screening for cervical cancer and 
the high proportion of women completing the referral, show that existing HIV prevention 
interventions provide a springboard for rapidly reaching women with timely, life-serving and 
easily adaptable cervical cancer prevention and treatment programmes such as “screen and 
treat”.12 
 
Both the Ghanaian and the rural Thailand studies assessed the safety, acceptability and feasibility 
of cryotherapy performed by trained nurses. Therefore the knowledge gap to be addressed is to 
find out if this approach is acceptable and safe to those accessing it in the Zimbabwean context 
and also to evaluate if it is feasible to effectively offer such a service in the context of the poorly 
resourced health system. There will be a need to look at certain aspects of the screening process 
such as follow up care of the patients with abnormal results, sustainability of the programme and 
whether the programme meets the screening standards set by WHO. The findings of the study 
will be discussed with the Ministry of Health and relevant policy makers. The findings of this 
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study will add knowledge required to develop effective health policies in Zimbabwe on an 
important aspect of women’s health. 
 
1.6Aim and objectives 
The aim of the study was to evaluate VIAC screening and immediate intervention (cryotherapy 
or LEEP) for the prevention of cervical cancer amongst women attending the United Bulawayo 
Hospital in Zimbabwe. The objectives of the study were: 
 To evaluate the safety of this approach - proportion experiencing severe bleeding, shock 
or requiring hospitalization during treatment, proportion with post treatment 
complications and proportion returning for an additional visit due to problems. 
 To evaluate patient satisfaction with and adherence to this approach-proportion that 
consented at their single visit, proportion of treatment postponed in order to consult with 
family members, proportion attending follow up appointments, proportion whose partners 
abstained from sex for four weeks after treatment by successfully adhering to home care 
instructions, proportion satisfied with the screening and treatment service. 
 To evaluate the technical feasibility of this approach-treatment performance rate in that 
eligible, proportion with treatment postponed due to break down of equipment. 
 To evaluate the clinical outcome - VIAC positive rate at 1 year post treatment at the 
clinic. 
 
2. METHODS 
 
2.1 Study design 
This was a descriptive cross sectional study using retrospective data from medical recordsof 
women attending the VIAC Clinic at United Bulawayo Hospital in the period 2010-2012. 
 
2.2 Setting for the study 
The study was carried out in a VIAC clinic located at the United Bulawayo Hospitals. The VIAC 
clinic was incorporated into an already existing Family Planning clinic. The clinic has been 
functional since June 2009 and has four rooms. One room was for data capturing, counseling for 
VIAC, contraception and HIV, and testing for HIV. The second room was a procedure room for 
VIAC and cryotherapy. The third room was a small theatre for LEEP and the fourth room was a 
toilet. The clinic employed four midwives trained in counseling, VIAC, cryotherapy and family 
planning. Registrars, gynaecologists and junior doctors trained in VIAC, cyrotherapy and LEEP 
also worked in this clinic. 
 
The duration of the training course was 14-21days. All nurses were expected to master VIAC 
and cryotherapy. Doctors were expected to master skills to perform VIAC, cryotherapy, LEEP, 
cautery, cone and punch biopsy provided they worked in institutions where complications of 
those procedures can be dealt with adequately. The participants were trained by two 
gynaecologists and two senior registrars. The learning approach used continual assessment of the 
participant learning, where the clinical trainer regularly informs the participants of their progress 
in learning new information and skills. Training and assessment were competency based. 
 
The guideline followed by the clinic was that those who were HIV negative were screened for 
cervical cancer every 3years while those who were HIV positive were screened once a year.
2 
The 
Stellenbosch University  https://scholar.sun.ac.za
8 
 
recommended optimal age for screening was defined as 30-39 years of age, expanding to 18- 65 
years as resources permitted. Those women who received cryotherapy or LEEP were reviewed 4 
weeks post treatment and then a year later. Figure 1 shows the flow of patients in the VIAC 
clinic. Patients with cancer of the cervix were referred to the gynecology clinic at the local 
referral hospital.  
 
2.3 Study population 
The study population included all women (4641) who were screened during the period 2010 – 
2012 were included. No pregnant women are screened at the clinic. 
 
2.4Data collection 
Data was collected by the researcher and three research assistants (another doctor and two clerks) 
from patients’ electronic medical records and captured in an Excel spread sheet. Data was 
collected to calculate the following variables: 
 
1. Proportion of VIAC positive women 
2. Proportion of women offered and accepted immediate post VIAC treatment 
3. Proportion of women who postponed treatment versus number of women who accepted it 
immediately 
4. Proportion of women who developed complications during treatment  
5. Proportion of women who developed complications after treatment (up to 6weeks)  
6. Proportion of women satisfied with the service 
7. Proportion of women supported by their spouses by abstaining from sex for four weeks 
following treatment 
8. Proportion of women found with invasive cervical cancer on first VIAC examination 
9. Proportion of women returning for review after 12 months post treatment. 
10. Proportion of women found VIAC positive on follow up after treatment. 
 
On arrival at the clinic patients were counseled for VIAC and HIV testing. At the end of the 
VIAC procedure patients were presented with their results and at the same time they were asked 
if they were satisfied with the decision they made to be tested. This was recorded in their notes 
and used to calculate the proportion of women satisfied with the service. 
 
2.5Data analysis 
Data was analyzed using Excel and Epi–Info software to generate tables and calculate 
frequencies, proportions, means and standard deviation with 95%confidence intervals. 
 
2.6 Ethical considerations 
Permission was obtained from the Health Authority of United Bulawayo Hospitals to conduct the 
research and ethical approval was obtained from the Health Research Ethics Committee of 
Stellenbosch University (Ref No HREC S13/02/036). Since there was no direct contact with the 
women and only the electronic medical records were used, there was a waiver of informed 
consent. 
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Figure 1: Clinical protocol for Zimbabwe safety, acceptability and feasibility project 
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3.0 RESULTS 
Two nurses screened 4641women using the protocol shown in Figure 1from 1
st
 January 2010 to 
31
st
 December 2012.All ages in the targeted range were represented and the mean age was 39 
(SD11.3) years as shown in Table I. Most patients (61.2%) attended the clinic with one or more 
of the following complaints: lower abdominal pain, vaginal discharge, vaginal bleeding, 
backache, dyspareunia or vaginal itchiness. Only 17.4% of women reported ever having had a 
Pap smear before. More than half (52.5%) of those screened tested HIV positive, some of them 
came to the clinic with their results while others were screened at the clinic on the VIAC day, 
while 10% did not know their HIV status meaning that they had refused testing. The mean age of 
sexual debut was 18 (SD 3.7) years and contraception was used by 61.9% of these women. 
 
Overall 10.8% of the women were VIAC positive and195/501 (38.9%) of those testing positive 
had suspected cancer or other problems requiring referral to a gynaecologist (see Figure 2).The 
large number of referrals to the gynaecologist could have been due to the fact that this was a new 
clinic and many symptomatic women were able to access the service for the first time. As shown 
in Table II 85/501(17.0%) of VIAC positive women were eligible for immediate treatment with 
cryotherapy and of these 98.1% received cryotherapy during the project period. On the other 
hand 221/501(44.1%) of VIAC positive women were eligible for immediate treatment with 
LEEP and of these 100% received LEEP during the project period. All the treated patients were 
followed up immediately after treatment and only one of the women treated experienced 
complications. With respect to their husbands or partners 97.7% of women who had received 
cryotherapy and 98.6% of those receiving LEEP were able to negotiate abstaining from sex in 
their relationships for 4 weeks. After treatment 97.7% were satisfied with their decision to be 
treated with cryotherapy while 98.6% were satisfied about their decision to be treated with 
LEEP.  
 
One year later 96.4% of the women who had received LEEP treatment came back for review and 
100% of the women who had received cryotherapy. At one year after treatment the VIAC 
positive rate was low, at 1.2% after cryotherapy and 3.2% after LEEP. 
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Figure 2: Patient flow in VIAC clinic 
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Table I: Programmatic factors and cervical cancer risk factors in relation to VIAC positive 
results (N=501) 
 
Marital status 
Variable Frequency Percentage 
-Single 69 13.7 
-Married 317 67.3 
-Widowed 89 17.4 
-Divorced 28 5.4 
Previous Pap smear done 
Variable Frequency Percentage 
-Yes 87 17.4 
-No 414 82.6 
HIV Status   
Variable Frequency Percentage 
-Positive 263 52.5 
-Negative 188 37.4 
-Unknown 50 10.0 
Initial complaints 
Variable Frequency Percentage 
-Vaginal bleeding 47 17.7 
-Vaginal discharge 41 7.5 
-Lower abdominal pain (LAP) 107 40.2 
-LAP and lower back pain 52 19.5 
-LAP and watery discharge 1 0.4 
-Lower back pain 6 2.3 
-Heavy menstruation 1 0.4 
-Post-coital bleeding 1 0.4 
-Watery vaginal discharge 6 2.3 
-LAP and vaginal bleeding 3 1.1 
-Dyspareunia 1 7.9 
Use of contraceptives 
 
Variable Frequency Percentage 
-Condoms 87 30.5 
-Oral contraceptives 102 35.8 
-Levonorgestrel implant 27 9.5 
-Tubal ligation 10 3.5 
-Depot progesterone injection 44 15.4 
-Intra-uterine contraceptive device 15 5.3 
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Table II: Selected clinical and programmatic outcomes 
 
 N % 
Screening (N=4641)   
VIA test positive 501 10.8 
Satisfied with their decision to be tested 4641 100.0 
Cryotherapy (N=85)   
Accepted immediate offer of cryotherapy 84 98.8 
Total cryotherapy performed among those eligible 84 98.8 
Treatments postponed due to staff or facility related issues 0 0.0 
Delayed treatment due to patient 1 1.9 
Clinic visit for perceived problem 0 0.0 
Major complications (bleeding, shock, hospitalization) 0 0.0 
Satisfied with their decision to be treated 84 97.7 
Complied with post cryotherapy instructions 82 97.7 
Attended follow up after 1-year 85 100.0 
Tested positive at 1-year 1 1.2 
LEEP (N=221)   
Accepted immediate offer of LEEP 221 100.0 
Total LEEP performed among those eligible 221 100.0 
Treatments postponed due to staff or facility related issues 0 0.0 
Delayed treatment due to patient 0 0.0 
Clinic visit for perceived problem 0 0.0 
Major complications (bleeding, shock, hospitalisation) 1 0.5 
Satisfied with their decision to be treated 218 98.6 
Complied with post LEEP instructions 218 98.6 
Attended follow up after 1-year 213 96.4 
Tested positive at 1-year 7/213 3.2 
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4. DISCUSSION 
The VIAC test rate was positive in 10.8%of all the women screened. Of those eligible, 17.0% 
received immediate cryotherapy, 44.1%received immediate LEEP, 1.9% delayed treatment and 
37.0% were referred to a gynaecologist. No major complications were recorded after cryotherapy 
or LEEP. Among those treated99.5% expressed satisfaction with their experience. Only2.6% of 
those treated at the clinic were VIAC positive one year later. Therefore, a single-visit approach 
to preventing cervical cancer using VIAC and immediate treatment with cryotherapy or LEEP 
can be safe, acceptable and feasible with good outcomes even in a low resource setting such as 
Bulawayo, Zimbabwe. 
 
Most of the patients came in late for screening, hence the large number of them that had 
advanced disease. The reasons for delay in screening were most likely due to the fact that this 
was the first VIAC screening clinic in the area. 
 
The safety and effectiveness of VIAC, cryotherapy and LEEP performed by nurses and junior 
doctors in this study was also seen in studies from Zambia, Ghana, India andThailand.
9,11,16  
The 
need for such task shifting to nurses and junior doctors in our setting is important because health 
care resources are constrained, infrastructure is limited, communication is difficult and 
physicians are often scarce. As part of routine quality assurance, aceto- white lesions one year 
post cryotherapy or LEEP is an indication for retreatment or referral. The positive VIAC test 
among the women who returned post cryotherapy and LEEP was 1.2% and 3.2% respectively. 
Given that the negative predictive value of VIAC has repeatedly been reported as 96% or greater, 
at least in primary care, the low test positive rate measured here is an important assurance to 
policy makers that cancers were prevented at the initial screening.
18,19,20 
 
The approach evaluated in this study was also acceptable to women and there was good 
adherence to the programmatic requirements for follow up and abstinence. Adherence to post 
procedure instructions and follow up was higher than a similar study in Ghana, which might be 
due to the emphasis on counseling in this clinic in Bulawayo.
9
A further study should look into 
the factors which resulted in a good follow up rate, as this is often cited as a hindrance to 
effective screening programmes in developing countries.
20 
 
Feasibility of sustaining and providing the service was also good and even in Zimbabwe it was 
possible to obtain the gas supply for cryotherapy, as well as the consumables necessary for VIAC 
and LEEP in this urban setting. There were no service-related treatment postponements and the 
clinic staff and facility were able to meet the demand for the service. VIAC with immediate 
cryotherapy or LEEP has also been shown to be cost-effective in other settings.
19
 
 
Mortality reductions of over 25% are predicted if at least 70% of targeted women are tested in 
each 5–10year screening cycle. It is not possible to calculate an accurate population coverage 
rate from the data in this study. However over time there will be need to assess if population 
coverage rates, needed to lower cervical cancer morbidity or mortality rates, can be achieved 
using this approach. Some of these women never could afford cervical cancer screening and they 
wanted to screened they then felt that if they presented with complaints then they had higher 
chances of being screened since the test was offered for free. 
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While the results indicate that a “single visit approach “ based on VIAC, cryotherapy and LEEP 
performed by trained nurses and doctors respectively is safe, acceptable and feasible more work 
is need to assess population coverage, cost, sustainability and quality assurance.
8,9,10
 The findings 
reported in the study support the viewpoint that this approach should be considered an alternative 
to prevention programmes based on cytology in areas where technical, infrastructural, and 
financial barriers exist.
8,9,10 
 
Although not the focus of this study Zimbabwe may need to consider the cost-effectiveness of 
embarking on immunization against HPV among 9-12 year olds to prevent cervical cancer. This 
approach has recently been adopted in South Africa.  
 
5. CONCLUSION 
The results indicate that a single visit approach based on VIAC, cryotherapy and LEEP 
performed by trained nurses and junior doctors respectively is safe and feasible in this low 
resourced urban setting in Zimbabwe. This approach was also acceptable to the women and there 
was good adherence to the programmatic requirements for follow up and abstinence. The 
treatment outcomes 1-year later were favorable with an overall VIAC positive test rate of only 
2.6%. Policymakers in this and similar low resource settings should consider prevention 
programmes for cervical cancer based on this approach rather than adopting models from more 
developed countries. 
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Appendix 1: Client post Cryotherapy instructions 
 
The health provider found a pre-cancer spot on your cervix. We destroyed this pre-cancer spot 
with freezing treatment called cryotherapy, which should make the cervix healthy again. 
 
Expectations 
 
After treatment, certain symptoms might occur. These symptoms disappear within two to four 
weeks. Do not let these symptoms worry you. 
 Your vagina will probably have some watery discharge. 
 You may feel pain of the type that is felt during periods. 
 You could also experience a little bleeding, but not as much as you experience during 
monthly periods. 
 
To allow the cervix to come back to being healthy again after cryotherapy avoid the 
following: 
 Sexual intercourse for a month, because you could be injured or get infected while it is 
healing. If you cannot abstain for one month, then ask your partner to use a condom. 
However, it is good to wait until you heal. 
 Putting anything for example tampons fingers, tissue, cotton, cloth, medicine, herbs, into 
your vagina for a period of one month. 
 Heavy work for a few days. 
 
The following are danger signs and you need to come back as soon as possible: 
 
 Foul smelling discharge (smelly pus in your vagina) 
 Bleeding in excess of the normal amount during menstruation 
 Very painful lower stomach pains. 
 A fever.(You feel hot and cold, shiver) 
 
When should you come back for review? 
You will need to go back for review after six weeks. Bring your client card with you. 
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Appendix 2: Cryotherapy Machine Instructions from Wallach 
 
Secure the pressure gauge block to the cylinder. The hand wheel should be hand-tightened 
only. 
1. Open the gas cylinder and observe the gas pressure. Gauge needle should move to the 
green area. Note: Green area denotes proper pressure for operation. Yellow area denotes 
the cylinder pressure is too low for operation and cylinder needs to be changed. Red area 
denotes excess pressure. If the needle is in the red area, follow ‘Venting the Cylinder’ 
instructions below. 
2. Choose appropriate sterilized cryotip with clear shield and screw onto end of machine. 
Hand-tightened only. Do not use tools to tighten. 
3. To see if apparatus is working, depress freeze trigger for several seconds. Tip should frost 
and smoke. Release freeze trigger and depress defrost trigger. Frost should disappear 
within 3-4 seconds. Note: Freeze trigger will automatically remain in the depressed 
position. You do not need to hold it down during the procedure. Depressing the defrost 
trigger will release the freeze trigger. 
4. Apply cryotip to moistened treatment area. It is recommended that a lubricant be applied 
to the treatment site. Depress the freeze trigger to freeze tissue. 
5. When finished with treatment shut off gas cylinder valve. Note:If treatment requires more 
than one tip,it is not necessary to shut off the gas cylinder valve while changing tips. 
Simply unscrew the tip presently in use, and replace with desired tips. 
6. To reduce concentration of nitrous oxide in the immediate cryosurgical area, you may 
vent the exhausting the gas by attaching one end of the scavenger hose to the exhaust port 
at bottom of the pressure gauge block. The other end of the hose goes a discharge 
location. Hose must have a minimum internal diameter of 6mm. 
Venting the Cylinder 
 
1. Close gas cylinder master valve first 
2. Slowly loosen hand wheel nut on attachment to gas cylinder. This releases residual gas in 
the feeder hose. When hissing sound stops, remove the pressure gauge block. 
3. Point the cylinder opening away from you and slowly open the cylinder master valvejust 
enough to hear gas steadily released. After approximately 15 seconds, close the valve. 
4. If the cylinder is being vented to reduce overfilled condition, reweigh the cylinder before 
proceeding. Reconnect the pressure gauge block. Open the gas cylinder valve and 
observe the gas pressure. The gauge needle should point to the green area. Repeat the 
procedure if it still points to the red area. 
Cryosurgical Unit Cleaning Instructions 
 
The cryosurgical unit can be wiped down with isopropyl alcohol (10%) but NOT chlorine 
solution. This wipes down procedure can include the black plastic handle, insulation shaft, 
white silicone gas hoses, gauge block and gas cylinder connector. Other methods include 
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heat, fluid (cold soaking) or steam are not recommended. NOTE: Moisture in lines and 
orifices of the cryoprobe, cryotip, and cryoconsole can cause sputtering, poor freeze, and 
other malfunctions. Whenever using fluids or steam to clean or sterilize, all gas lines and 
cryotip orifices must be plugged or corrosion may result. Plugs are available from the 
manufacturer. 
 
 
Cryotip Cleaning Instructions 
1. Remove the disposable shield from the cryotip and discard. 
2. Plug the cryotip before cleaning and sterilizing with silicone plug. 
3. Scrub the cryotip to remove blood and particles 
4. Rinse with water 
5. Cyotips can be steam sterilized by pre-vacuum or gravity with a cycle temperature of 135 
degrees celcius. The cycle time is 10 minutes with drying time of 10 minutes. NOTE: at 
no time should chlorine mixtures (bleach) or iodine-based products be used for soaking 
or cleaning cryotips. Cryotips will degrade if exposed to such solutions. 
6. Attach new disposable plastic shield to the cryotips, ensuring that the tabs on the shields 
are correctly fitted into the groove on the metal tip. 
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Appendix 3: Client Information on LEEP 
 
What is LEEP (Loop Electrical Excision Procedure)? 
 
This is a procedure whereby a small wire is used to remove the pre-cancer spot from the 
cervix which is then sent to the laboratory for evaluation. 
 
Expectations after LEEP 
After LEEP a woman will have brown, black, or blood-tinged discharge from her vagina for 
about 2 weeks. 
 
To allow the cervix to come back to being healthy again after LEEP avoid the 
following: 
 Sexual intercourse for one month, because your cervix could be injured or get 
infected while it is healing. If you cannot abstain for one month weeks, then ask your 
partner to use a condom. However, it is good to wait until you heal. 
 Putting anything for example tampons, fingers, tissue, cotton, cloth, medicine, herbs 
into your vagina for a period of one month. 
 Heavy work for a few days. 
The following are danger signs and you need to come back as soon as possible: 
 Foul smelling discharge (smelly pus in your vagina). 
 Bleeding in excess of the normal amount during menstruation. 
 Very painful lower stomach pains. 
 A fever. (You feel hot and cold, shiver) 
When should you come back for review? 
You will need to go back for review after six weeks. Bring your client card with you. 
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Appendix 4 Tips for LEEP Operators 
 
1. In order to remove the entire lesion and transformation zone with one pass, always 
choose a loop electrode that is greater than the width of the lesion and transformation 
zone that is to be removed; otherwise the lesion should be removed with multiple passes. 
2. The depth of the loop (height from the cross bar to the tip of the wire which) should be at 
least 5mm. 
3. Power setting for different size electrode balls 
A.  3mm-30watts 
B. 5mm-50watt 
4. Power settings for different size electrodes 
A. 1.0x1.0 cm-30 watts 
B. 1.5x0.5cm-35 watts 
C. 2.0x0.8cm-40 watts 
D. 2.0x1.2cm-50 watts 
5. Steps to obtain cervical anesthesia 
a. Equipment: 5ml syringe,25 or 27 gauge needle 
b. At each 4 different sites around ecto-cervix (3,6,9,12o’clock) inject 1mlof lignocaine, try 
not to exceed a total of 5ml. 
c. The injection is placed 1-2 mm deep into the ecto-cervical stroma, at the periphery of the 
lesion and transformation zone. 
d.  A mixture of 1% lignocaine and vasopressin (not more than one pressor unit) or 1% 
lignocaine and epinephrine 1:100000 may be used to decrease bleeding. The mixture of 
lignocaine and adrenalin may cause leg cramps and palpitations; however, this can be 
avoided if infiltration is sub-epithelial. 
Tips on the LEEP procedure 
 
1.  Make a false (practice) pass with no electrical current before excising the lesion  
2. At the beginning of excision, introduce the loop electrode 5mm outside the outer 
boundary of the lesion; do not push the electrode in, but let it cut its own way; the 
operator should simply provide directional guidance. 
3. Throughout the excision the operator guides the loop electrode along, parallel to the 
surface of the tissue. 
4. The lesion can be excised from right to left, left to right, posterior to anterior, but not 
anterior to posterior. During the latter scenario blood or excised tissue curling downward 
may obscure the visual field. 
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Appendix 5: Consent form for cyrotherapy/LEEP/Cautery/punch biopsy 
 
Hospital ID number……………………………………… 
To:………………………………………………………………....Clinic/Hospital ZCCPP 
I……………………………………………….ID number……………………………...…. 
Of address ………………………….……………………………………………………… 
………………………………………………………………………………………………
……………………………………………………………………………………………… 
 
Hereby consent to undergo the following operation/procedure 
 
 Cryotherapy 
 Cauterization 
 Loop electrical excision procedure 
 Punch biopsy 
The nature, benefits, side effects alternatives, type of anesthesia, and any extra 
procedures linked with complications of the above have been clearly explained to me. I 
also consent to any further procedures as may be found necessary during the course of the 
above procedure. 
 
Signed……………………………………..Date………………………………………… 
 
Witness……………………………………Date………………………………………… 
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Appendix 6: FIGO staging cervical cancer 
 
Stage I is carcinoma strictly confined to the cervix: extension to the uterine corpus 
should be disregarded. The diagnosis of both Stages IA1 and IA2 should be based on 
microscopy. 
 
Stage IA: Invasive cancer identified only microscopically. Invasion is limited to 
measured stromal invasion with maximum depth of 5mm and no wider than 7mm. 
Stage IA2: Measured invasion of the stroma no greater than 3mm but no greater than 
5mmin depth and no wider than 7mm in diameter. 
Stage IB: Clinical lesion confined to the cervix or preclinical lesions greater than Stage 
IA. All gross lesions superficial invasion are Stage 1B cancers. 
Stage IB1: Clinical lesions no greater than 4cm in size. 
Stage IB2: Clinical lesions greater than 4cm in size. 
 
Stage II 
 
Stage II is carcinoma that extends beyond the cervix, but does not extend into the pelvic 
wall. The carcinoma involves the vagina, but not as far as the lower third. 
 
Stage IIA: No obvious parametrial involvement. Involvement of up to the upper two 
thirds of the vagina. 
 
Stage IIB: Obvious parametrial involvement, but not into the pelvic side wall. 
 
Stage III 
Stage III is carcinoma that has extended into the pelvic side wall. On rectal examination, 
there is no cancer- free space between the tumor and the pelvic side wall. The tumor and 
the pelvic wall. The tumor involves the lower third of the vagina. All cases with 
hydronephrosis or a non-functioning kidney are Stages 111 cancer. 
Stage IIIA:  No extension into the pelvic side wall, but involvement of the lower third of 
the vagina. 
 
Stage IIIB:  Extension into the pelvic side wall or hydronephrosis or non-functioning 
kidney. 
 
Stage IV is carcinoma that has extended beyond the true pelvis or has clinically involved 
the mucosa of the bladder and/or rectum. 
 
Stage IVA: Spread of the tumour into adjacent pelvic organs. 
 
Stage IVB: Spread to distant organs. 
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